Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 427.00
Bid: 426.90
Ask: 427.10
Change: 0.50 (0.12%)
Spread: 0.20 (0.047%)
Open: 427.00
High: 427.70
Low: 422.80
Prev. Close: 426.50
RTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Q4 2020 Acquisitions and Trading Update

8 Jan 2021 07:00

RNS Number : 0002L
Rentokil Initial PLC
08 January 2021
 

 

8 January 2021

Rentokil Initial plc - Q4 2020 Acquisitions and Trading Update

A very strong end to the year for M&A in our key North America pest control market with continued strong trading boosted by momentum in disinfection services

Rentokil Initial plc (FTSE: RTO, "the Company") announces today the acquisition of Environmental Pest Service ('EPS'), a full-service, commercial and residential pest control company based in Tampa, Florida.

EPS was ranked 15th in the PCT Magazine 2020 Top 100 listing of leading US pest control companies and generated annualised revenues of c.$82m (£60m) in 2020. EPS employs c.640 people (of which 386 are in service roles) in 30 branches across four separate regions: East Florida; West Florida; North Georgia; and North Carolina. It has two brand names, Arrow Environmental and Bug Out.

In addition to the acquisition of EPS, we have acquired a further eight high quality pest control companies in North America in Q4, with combined annualised revenues of c.$62m (c.£48m) in 2020.

Total acquisitions in 2020

For the full year ended 31 December 2020, we have acquired 23 new businesses, with annualised revenues of over £150m, for a cash spend of c.£180m (of which c.£150m was in H2). This excludes the consideration for EPS which was paid at the beginning of January 2021.

Announcement of Preliminary Results and Updated Guidance for 2020

Rentokil Initial plc will announce its 2020 Preliminary results on Thursday, 4 March. In our Q3 Trading Statement last October, we indicated that despite continued uncertainty across our business as a result of the ongoing pandemic, we were hopeful of being able to maintain the momentum we had seen in Q3 into the fourth quarter which would result in an outcome for the full year at least in line with expectations. Trading across both our Hygiene and Pest Control categories has continued to be strong in Q4 - primarily reflecting continued strong sales from one-off disinfection services - and we now expect the final outcome for the year to be slightly above the top end of the range of current market expectations for Adjusted PBTA*.

We are looking to the future with confidence. However, while global vaccination programmes offer hope that we will see an end to the pandemic, the financial outlook for 2021 inevitably remains uncertain, in particular with limited visibility on the sustainability of one-off disinfection services, the recent strengthening of sterling, and the undetermined impacts arising from recently rising cases of COVID-19 globally and new and prolonged country lockdowns. We look forward to providing a further update with our full year results on 4 March.

Andy Ransom, Chief Executive of Rentokil Initial plc, said:

"Despite the impact of COVID-19 on our business in 2020, we have exited the year in a strong position, with the trading momentum of Q3 continuing throughout Q4 and with an excellent overall delivery of M&A, which significantly accelerated as the year drew to a close. We have gained approximately 2000 new colleagues from acquisitions in 2020, and I am delighted to welcome them all to Rentokil Initial.

"I am also very pleased to announce our acquisition of Environmental Pest Service. EPS is a high-quality company of significant scale with a strong reputation for service delivery and technical ability, and with a culture which will make an excellent fit with our own. This acquisition is very much in line with our strategy to acquire pest control businesses that build customer density and add to our scale in key local markets - by acquiring EPS we can immediately add density, provide improved customer service, and provide incremental revenue to several of our sub-scale existing Rentokil locations on the Florida Gulf Coast, as well as build on our existing presence in north eastern Florida, metro Atlanta and North Carolina."

Investor / Analyst enquiries:

Katharine Rycroft, Investor Relations

Rentokil Initial plc

07811 270 734

Media enquiries:

Malcolm Padley, Corporate Communications

Rentokil Initial plc

07788 978 199

 

* Our Company-compiled current range of analyst forecasts for Adjusted PBTA for 2020 is £292m to £337m.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQEAAFXESLFEAA
Date   Source Headline
23rd Apr 20249:30 amRNSHolding(s) in Company
18th Apr 20247:00 amRNSQ1 Trading Update
2nd Apr 20241:28 pmRNSBlock listing Interim Review
2nd Apr 202412:17 pmRNSTotal Voting Rights
27th Mar 202410:23 amRNSAnnual Financial Report
19th Mar 20242:05 pmRNSAdditional Listing
14th Mar 202410:19 amRNSDirector/PDMR Shareholding
7th Mar 20247:00 amRNSFinal Results
1st Dec 20237:00 amRNSNorth American Management Changes
10th Nov 20232:28 pmRNSDirector/PDMR Shareholding
3rd Nov 20234:26 pmRNSHolding(s) in Company
3rd Nov 20234:22 pmRNSDirector/PDMR Shareholding
1st Nov 202312:50 pmRNSHolding(s) in Company
31st Oct 202311:45 amRNSHolding(s) in Company
30th Oct 20233:03 pmRNSDirector/PDMR Shareholding
30th Oct 202311:55 amRNSCredit rating update
19th Oct 20237:00 amRNSQ3 Trading Update
2nd Oct 202311:35 amRNSBlock listing Interim Review
27th Sep 20232:35 pmRNSDirector/PDMR Shareholding
1st Aug 202312:42 pmRNSDirector/PDMR Shareholding
27th Jul 20237:00 amRNS2023 Interim Results
29th Jun 20239:00 amRNSNotice of Management Presentation
23rd Jun 20235:58 pmRNSDirector/PDMR Shareholding
19th May 20233:03 pmRNSDirector/PDMR Shareholding
12th May 20239:09 amRNSDirector/PDMR Shareholding
11th May 20239:17 amRNSResult of AGM
28th Apr 202310:55 amRNSHolding(s) in Company
21st Apr 20232:41 pmRNSDirector/PDMR Shareholding
20th Apr 20237:00 amRNSQ1 Trading Update
4th Apr 20239:37 amRNSAnnual Financial Report
3rd Apr 202310:08 amRNSBlock listing Interim Review
23rd Mar 20239:42 amRNSDirector/PDMR Shareholding
20th Mar 20234:47 pmRNSDirector/PDMR Shareholding
16th Mar 20237:05 amRNSDirectorate Change
16th Mar 20237:00 amRNSFinal Results
9th Mar 20239:23 amRNSDirector Declaration
27th Feb 20238:55 amRNSNotice of Management Presentation
9th Nov 20224:33 pmRNSDirector Declaration
1st Nov 20222:25 pmRNSCorrection: Q3 Trading Update
1st Nov 20227:00 amRNSQ3 Trading Update
31st Oct 20224:03 pmRNSTotal Voting Rights
24th Oct 20225:15 pmRNSHolding(s) in Company
21st Oct 20224:42 pmRNSHolding(s) in Company
20th Oct 202212:35 pmRNSHolding(s) in Company
19th Oct 202211:43 amRNSHolding(s) in Company
18th Oct 20225:22 pmRNSHolding(s) in Company
17th Oct 20226:07 pmRNSHolding(s) in Company
17th Oct 202211:51 amRNSHolding(s) in Company
14th Oct 20224:39 pmRNSHolding(s) in Company
14th Oct 20224:37 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.